acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet [Repan]
RxNorm concept 211194, branded drug (sbd). Prescribable name: Repan 50 MG / 325 MG / 40 MG Oral Tablet.
- RxCUI
- 211194
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/211194 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
APAP 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet [Repan]; Repan (APAP 325 MG / butalbital 50 MG / caffeine 40 MG) Oral Tablet
Related concepts
- acetaminophen 325 MG (SCDC, consists of)
- butalbital 50 MG (SCDC, consists of)
- caffeine 40 MG (SCDC, consists of)
- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG [Repan] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Repan (BN, has ingredient)
- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00642016210
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 211194 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/211194 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 211194. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.